Publications - AIGHD

Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants

Authored by: NCD Risk Factor Collaboration (NCD-RisC)* In: The Lancet online 2016 November 15, doi: 10.1016/S0140-6736(16)31919-5 *Hendriks, M. e.a. Raised blood pressure is an important risk factor for cardiovascular diseases and chronic kidney disease. We estimated worldwide trends in mean systolic and mean diastolic blood pressure, and the...

17 November, 2016

Tradeoffs in Bedaquiline Introduction Policies: A Model Based Analysis

Authored by: Kunkel A, Cobelens F, Cohen T. In: PLoS Med 2016;13:e1002142. Bedaquilline, a new drug to treat tuberculosis, is currently only recommended for use in patients with advanced forms of drug resistance (XDR-TB and "pre-XDR-TB’). In a collaboration with Yale School of Public Health we used...

20 October, 2016

Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?

Authored by: Ssengooba W, Respeito D, Mambuque E, Blanco S, Bulo H, Mandomando I, de Jong BC, Cobelens FG, García-Basteiro AL. In: PLoS One 2016;11:e0162833. In this study done in Mozambique we analyzed whether information about sputum bacterial burden provided by the GeneXpert diagnostic test is associated...

20 October, 2016

Limited Benefit of the New Shorter MDR-TB Regimen in Europe

Authored by: Lange C, Duarte R, Fréchet-Jachym M, Guenther G, Guglielmetti L, Olaru ID, Oliveira O, Rumetshofer R, Veziris N, van Leth F; European MDR-TB database collaboration. In: Am J Respir Crit Care Med. 2016 Sep 29. [Epub ahead of print] No abstract available. https://www.ncbi.nlm.nih.gov/pubmed/27685538...

14 October, 2016

Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania

Authored by: Senkoro M, Kumar AM, Chinnakali P, Mfinanga SG, Egwaga S, Kamara V, van Leth F, Hinderaker SG. In: Int J Tuberc Lung Dis. 2016 Oct;20(10):1326-1333. https://www.ncbi.nlm.nih.gov/pubmed/27725043 ...

14 October, 2016

An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype

Authored by: Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Nelson M, Montaner JS, Lane HC, Larder BA; RDI Data and Study Group. In: J Antimicrob Chemother. 2016 Oct;71(10):2928-37. PMID: 27330070 https://www.ncbi.nlm.nih.gov/pubmed/27330070...

07 October, 2016

Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa

Authored by: Boender TS, Kityo CM, Boerma RS, Hamers RL, Ondoa P, Wellington M, Siwale M, Nankya I, Kaudha E, Akanmu AS, Botes ME, Steegen K, Calis JC, Rinke de Wit TF, Sigaloff KC. In: J Antimicrob Chemother. 2016 Oct;71(10):2918-27. PMID: 27342546 https://www.ncbi.nlm.nih.gov/pubmed/27342546...

07 October, 2016

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

Authored by: Boender TS, Hamers RL, Ondoa P, Wellington M, Chimbetete C, Siwale M, Labib Maksimos EE, Balinda SN, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Stevens W, Rinke de Wit TF, Sigaloff KC. In: J Infect Dis. 2016 Sep 15;214(6):873-83. PMID: 27402780 https://www.ncbi.nlm.nih.gov/pubmed/27402780...

07 October, 2016

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa

Authored by: Inzaule SC, Ondoa P, Peter T, Mugyenyi PN, Stevens WS, de Wit TF, Hamers RL. In: Lancet Infect Dis. 2016 Aug 25. pii: S1473-3099(16)30118-9. doi: 10.1016/S1473-3099(16)30118-9. PMID: 27569762 https://www.ncbi.nlm.nih.gov/pubmed/27569762...

07 October, 2016

Next-generation sequencing and HIV drug resistance surveillance

Authored by: Hamers RL, Paredes R. In: Lancet HIV. 2016 Sep 14. pii: S2352-3018(16)30151-5. doi: 10.1016/S2352-3018(16)30151-5. PMID: 27658866 http://www.ncbi.nlm.nih.gov/pubmed/27658866...

07 October, 2016

Archive

Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants

Tradeoffs in Bedaquiline Introduction Policies: A Model Based Analysis

Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?

Limited Benefit of the New Shorter MDR-TB Regimen in Europe

Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania

An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype

Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa

Next-generation sequencing and HIV drug resistance surveillance

Contact

QUICK LINKS